its amazing how he refers to one sentence of the nomura report,...

its amazing how he refers to one sentence of the nomura report, turns it around with stating that whole paragraph and uses that as a way to back up his case, even though he didnt state the positive results that came out of the trial.

below is the full paragraph taken from the nomura report.

C-Vac results
19% of patients responded to therapy (CA-125 reduction or prolonged stabilization) and
47% of patients had disease stabilization (CA-125 remained stable):
• No C-Vac therapy-related toxicity
• Ovarian tumours respond to therapy with CA125 reduction or stabilization
• Progression Free Survival averaged 127 days (95% confidence limits 96 to 219 days)
We note that these were not statistically significant results. Hence, the Phase III clinical
trial will assess statistical significance of the response to C-Vac.

If the report was stating how 'apparently bad' the results were to date, and likely to be then why was it "initiating coverage with a buy recommendation with a target of 31c". I wish i knew what his motives were. Maybe the final scare before upcoming postive results, to try and get in whilst everyone is running? noone knows i guess.